MktsMarkets

CervoMed Inc.
NASDAQ: CRVOKey statistics
CRVO News
Stories mentioning CRVO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 9.00 | 323.00 | 1,758 | 1,917 | 2,162 | 1,940 | 3,289 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 5,135 | 5,830 | 6,040 | 5,109 | 4,838 | 7,087 | 5,125 | 3,772 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 8,111 | 8,340 | 8,367 | 8,374 | 7,220 | 9,403 | 7,336 | 6,284 |
| Operating Income (Loss) | (8,111) | (8,332) | (8,044) | (6,616) | (5,303) | (7,241) | (5,396) | (2,995) |
| Interest Income | 147.00 | 241.00 | 319.00 | 368.00 | 409.00 | 532.00 | 646.00 | 678.00 |
| Interest Expense | ||||||||
| Other Expense | (1.00) | 3.00 | (1.00) | (10.00) | 0.00 | 2.00 | (3.00) | 0.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (7,964) | (8,087) | (7,727) | (6,258) | (4,894) | (6,706) | (4,754) | (2,317) |
| Earnings Per Share (Basic) | (0.86) | (0.89) | (0.84) | (0.70) | (0.56) | (0.83) | (0.55) | (0.27) |
| Earnings Per Share (Diluted) | (0.55) | |||||||
| Weighted Average Shares Outstanding (Basic) | 9,258 | 9,042 | 9,253 | 8,951 | 8,703 | 8,073 | 8,703 | 8,703 |
| Weighted Average Shares Outstanding (Diluted) | 8,703 | |||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRVO
CervoMed Inc. (NASDAQ: CRVO) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRVO. It last traded at $1.64 (Nov 2, 2026, 4:00 PM ET), up 2.5% on the day. That gives CervoMed a market capitalisation of $24.2M.
Over the past 52 weeks CRVO has traded between $1.60 and $10.00.
Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $8.0M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $0 | -$8.0M | — |
| Dec 31, 2025 | $9.0K | -$8.1M | -89855.6% |
| Sep 30, 2025 | $323.0K | -$7.7M | -2392.3% |
| Jun 30, 2025 | $1.8M | -$6.3M | -356.0% |
From CervoMed’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…